Moderators of Cognitive Behavioral Treatment for Insomnia on Depression and Anxiety Outcomes.

Moderators of Cognitive Behavioral Treatment for Insomnia on Depression and Anxiety Outcomes.
复制标题

失眠症认知行为治疗对抑郁和焦虑结果的调节因素。

DOI:
10.1007/s11920-022-01326-3
复制
发表时间:
2022-03
影响因子:
6.7
通讯作者:
Asarnow LD
Asarnow LD
中科院分区:
医学2区
文献类型:
--
作者:
Mirchandaney R;Barete R;Asarnow LD

文献摘要

参考文献

被引文献

相似文献

我们重点回顾了有充分把握的随机对照试验,介绍了最近关于失眠症认知行为疗法(CBT-I)改善失眠症患者抑郁和焦虑结局的潜力的研究,这些患者患有以下共病精神障碍:重度抑郁症(MDD),广泛性焦虑症(GAD)或创伤后应激障碍(PTSD)。我们还研究了CBT-I对这一人群中抑郁和焦虑结果的潜在调节因素。尽管合并症发生率很高,但目前对MDD、GAD和PTSD的行为和药物治疗并不能显著靶向或改善失眠症状;即使在经历缓解的患者中,残留失眠也非常常见。失眠在抑郁和焦虑的发生和维持中起着关键作用,用CBT-I治疗失眠可能会改善MDD、GAD和PTSD患者的总体结局。CBT-I在改善共病精神障碍患者的失眠症状方面上级传统的抑郁/焦虑治疗。关于CBT-I(单独使用或结合抑郁/焦虑治疗)是否能有效改善总体MDD、GAD和PTSD结局,结果好坏参半。晚上的昼夜节律偏好和抑郁/焦虑症状的严重程度可能会缓和CBT-I对抑郁和焦虑结果的影响。在线版本包含补充材料,可通过10.1007/s11920-022-01326-3获取。
With a focus on reviewing adequately powered randomized controlled trials, we present recent research on the potential of cognitive behavioral therapy for insomnia (CBT-I) to improve depression and anxiety outcomes among patients with insomnia and one of the following comorbid psychiatric disorders: major depressive disorder (MDD), generalized anxiety disorder (GAD), or posttraumatic stress disorder (PTSD). We also examine potential moderators of CBT-I on depression and anxiety outcomes in this population. Despite high comorbidity rates, current behavioral and pharmacological treatments for MDD, GAD, and PTSD do not substantially target or improve insomnia symptoms; residual insomnia is exceedingly common even among patients who experience remission. Insomnia plays a critical role in the onset and maintenance of depression and anxiety, and treating insomnia with CBT-I may improve global outcomes for patients with MDD, GAD, and PTSD. CBT-I is superior to traditional depression/anxiety treatment in improving insomnia symptoms among patients with comorbid psychiatric disorders. Results are mixed on whether CBT-I (either alone or augmented with depression/anxiety treatment) is effective in improving overall MDD, GAD, and PTSD outcomes. Evening circadian preference and depression/anxiety symptom severity may moderate the effect of CBT-I on depression and anxiety outcomes. The online version contains supplementary material available at 10.1007/s11920-022-01326-3.
DOI: 10.1093/sleep/zsx108
发表时间: 2017-08-01
期刊: SLEEP
影响因子: 5.6
作者:
Blom, Kerstin;Jernelov, Susanna;Kaldo, Viktor
通讯作者: Kaldo, Viktor
DOI: 10.5665/sleep.3658
发表时间: 2014-05-01
期刊: SLEEP
影响因子: 5.6
作者:
Chan, Joey Wing Yan;Lam, Siu Ping;Wing, Yun-Kwok
通讯作者: Wing, Yun-Kwok
DOI: 10.1016/s0165-0327(98)00051-2
发表时间: 1999-01-01
影响因子: 6.6
作者:
Chelminski, I;Ferraro, FR;Plaud, JJ
通讯作者: Plaud, JJ
DOI: 10.1007/s11920-015-0554-4
发表时间: 2015-03
影响因子: 6.7
作者:
Bernert RA;Kim JS;Iwata NG;Perlis ML
通讯作者: Perlis ML
DOI: 10.5664/jcsm.5018
发表时间: 2015-01-01
影响因子: 4.3
作者:
Bei, Bei;Ong, Jason C.;Manber, Rachel
通讯作者: Manber, Rachel